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An Avian Retrovirus Uses Canonical Expression and Processing
Mechanisms To Generate Viral MicroRNA
Yongxiu Yao,a Lorraine P. Smith,a Venugopal Nair,a Mick Watsonb
‹Viral Oncogenesis Group, The Pirbright Institute, Compton Laboratory, Compton, Berkshire, United Kingdoma; Ark-Genomics, The Roslin Institute, R(D)SVS, University of
Edinburgh, Division of Genetics and Genomics, Easter Bush, Midlothian, United Kingdomb
To date, the vast majority of known virus-encodedmicroRNAs (miRNAs) are derived from polymerase II transcripts encoded by
DNA viruses. A recent demonstration that the bovine leukemia virus, a retrovirus, uses RNA polymerase III to directly tran-
scribe the pre-miRNA hairpins to generate viral miRNAs further supports the common notion that the canonical pathway of
miRNA biogenesis does not exist commonly among RNA viruses. Here, we show that an exogenous virus-specific region, termed
the E element or XSR, of avian leukosis virus subgroup J (ALV-J), a member of avian retrovirus, encodes a novel miRNA, desig-
nated E (XSR) miRNA, using the canonical miRNA biogenesis pathway. Detection of novel microRNA species derived from the E
(XSR) element, a 148-nucleotide noncoding RNAwith hairpin structure, showed that the E (XSR) element has the potential to
function as a microRNA primary transcript, demonstrating a hitherto unknown function with possible roles in myeloid leukosis
associated with ALV-J.
Retroviruses are a large group of enveloped viruses associatedwith a variety of diseases in a wide range of host species. Avian
retroviruses, the Rous sarcoma virus (RSV) and avian leukosis
virus (ALV), are historically known for their ability to induce a
number of types of cancer in poultry (1). In addition to their
pathogenic roles, retroviruses have provided significant insights
into transcriptional regulation in a cell-type-specific manner (2).
The retroviral genome includes a number of cis-acting elements
(3). One such element is the 148-nucleotide exogenous virus-spe-
cific region (E or XSR) identified in the SR-A and Pr-C strains of
RSV at the 5= and the 3= sides of the src gene, respectively (4, 5).
The functions of the E (XSR) element are not clear although re-
quirement of a 400-nucleotide region that included the E (XSR)
element for oncogenicity of the recombinant avian retrovirus
NTRE7has been shown (6). TheE (XSR) sequence exhibits several
unusual features; it has a noncoding RNA capable of forming
characteristic hairpin structures (7). From its location at two dif-
ferent sites on either side of the src gene in the two RSV strains, it
is clear that the functions of E (XSR) can be exerted over distance.
Based on these observations, it was speculated that E (XSR) may
function as a transcriptional enhancer (5).
Interest in the E (XSR) element was revived when it was dem-
onstrated in the 3= noncoding region of the genome of HPRS-103,
the ALV subgroup J (ALV-J) prototype virus (8), identified in the
United Kingdom in 1988 as the causative agent of myeloid leuko-
sis, which rapidly became aworldwide health andwelfare problem
in chickens (9–13). The E (XSR) sequence is conserved in the
majority of the ALV-J isolates although deletions ormodifications
in this sequence have also been seen (13–16). The role of the E
(XSR) element in the pathobiology of ALV-J is not known al-
though potential C/EBP and c-Ets-1 binding sites have been pre-
dicted in the sequence (13, 14). However, ALV-J strains with de-
letions or mutations in the E (XSR) element have also been
isolated from clinical cases (9–11, 14, 17). Our previous studies
using HPRS-103 clones with precise deletions in the E (XSR) ele-
ment indicated that these elements are essential for oncogenicity,
but this was related to the genetic background of the birds (7).
Despite the presence of the E (XSR) element and its association
with the oncogenicity of RSV and ALV-J, the molecular mecha-
nisms of the E (XSR) element functions remain unclear. Although
an enhancer-like function has been speculated (5, 14), firm sup-
porting evidence is still lacking.
In many organisms, including several viruses, microRNAs
(miRNAs) are well recognized as major regulators of gene expres-
sion (18). Given their profound ability to regulate multiple tar-
gets, these molecules are exploited particularly by several DNA
viruses as tools for manipulating the cellular environment (19,
20). RNA viruses are generally thought not to contain pre-miRNA
structures to avoid endonuclease-mediated cleavage of the ge-
nome, antigenome, and mRNAs. Although retroviruses have not
been widely documented to exploit the miRNA pathway (21), a
recent demonstration of a conserved cluster of RNA polymerase
III (Pol III)-transcribed miRNAs from the bovine leukemia virus
(BLV) genome (22, 23) showed the potential of retroviruses to
encode miRNAs. The E (XSR) element sequences from ALV-J
strains show hairpin-like structures suggestive of miRNA precur-
sors although the existence of any mature miRNA has not been
demonstrated in ALV-J-infected/transformed cells. Using a deep-
sequencing approach on one of the ALV-J-transformed cell lines,
we identified a novel small-RNA population encoded fromwithin
the E (XSR) element.
MATERIALS AND METHODS
Cells. HEK293T cells and the chicken embryo fibroblast (CEF) cell line
DF-1 (24) were maintained in Dulbecco’s modified Eagle’s medium
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(DMEM) supplemented with 10% fetal calf serum (FCS) (Sigma). A re-
ticuloendotheliosis virus T (REV-T)-transformed turkey spleen cell
(TSC) line, AVOL-1T, and IAH30, a turkey macrophage (M) cell line
(25) transformed by the acutely transforming ALV subgroup J 966 virus
with a transduced v-myc oncogene (26), were grown at 38.5°C in 5%CO2
in RPMI 1640 medium containing 10% FCS, 2% chicken serum, 10%
tryptose phosphate broth, 0.1% 2-mercaptoethanol, and 1% sodium py-
ruvate. AVO4-1B3 cells, an avian blastoderm cell line transformed by
acutely transforming ALV-J isolate 1B (27), was maintained in Eagle’s
minimal essential medium (EMEM) supplemented with 10% FCS. Tur-
key spleen cells were prepared from spleen tissues of uninfected turkey by
using Histopaque-1083 (Sigma-Aldrich) density gradient centrifugation.
Chicken macrophages were prepared from bone marrow of adult unin-
fected chickens using procedures described previously (12). Briefly, fem-
oral bone marrow was flushed out with RPMI medium, and the contents
were passed through a cell sieve. After Histopaque-1083 density gradient
centrifugation, the cells from the interface were collected, washed twice
using RPMImedium supplemented with 5% FCS and 5% chicken serum,
plated into 60-mm dishes, and cultured at 38.5°C in 5% CO2. The me-
diumwas changed after 3 days, and the cells were used for virus infection.
Plasmids. The miR-155 expression plasmid pEF6-Bic was de-
scribed previously (28). The MHV-miR-M1-7-3p expression plasmid
pIDTSmartKan-MHV68-M1-7 was kindly provided by Chris Sullivan,
University of Texas, Austin, TX. The E (XSR) miRNA expression cassette
was PCR amplified from HPRS-103 genomic DNA with primers 5=-TCG
ATAGGAAGCTTAAAGCAGTGCATGGGTAGGGGT-3= and 5=-TCAC
GTAATCTAGACCACCTTACTTCCACCAATCGACG-3=. The isolated
fragments were either cloned into pGEM-T-easy by TA cloning or into
pcDNA3.1-His/myc via restriction enzyme sites HindIII and XbaI. A lu-
ciferase sensor reporter was constructed by synthesizing four tandem re-
peats of artificial target sites with a perfect match to E (XSR) miRNA as
sense and antisense oligomers; the constructwas annealed and cloned into
the 3= untranslated region (UTR) of the Renilla luciferase gene through
the NotI-XhoI site in the psiCHECK-2 vector (Promega). A control mu-
tant reporter construct (sensor-mu) was generated alongside the wild-
type reporter construct to be the negative control. In the mutant con-
struct, nucleotides 2, 4, 6, and 8 of the microRNA response element
(MRE)were changed to different bases, thus preventing recognition of the
target site by the miRNA. In all cases, the cloned sequences were con-
firmed by sequence analysis.
Deep sequencing of an IAH30 small-RNA library. RNA extraction
formiRNA profiling was carried out as previously described (29) using an
miRVana miRNA isolation kit (Ambion, United Kingdom). Sequencing
of the miRNAs was carried out on an Illumina GAIIx platform by GATC
Biotech. After sequencing, adaptor and primer/dimer sequences were re-
moved, yielding approximately 1.5 million 36-bp single-end reads. Using
the Novoalign short-read mapper (Novocraft, Selangor, Malaysia), we
mapped the reads to the known chicken mature miRNAs downloaded
frommiRBase (www.miRBase.org) and the HPRS-103 genome sequence
(GenBank accession number Z46390.1). To correct for differences in li-
brary size and sequencing depth, raw mapped-read counts were scaled to
reads per kilobase per million sequenced reads (30).
Northern blotting. Total RNA was extracted from cultured cells with
an miRNeasy Kit (Qiagen) according to the manufacturer’s instructions.
Samples of 20 g of total RNA were resolved using a 15% polyacryl-
amide–1 Tris-borate–EDTA–8M urea gel and blotted to a GeneScreen
Plus membrane (Perkin-Elmer). The probe sequences of DNA oligonu-
cleotides with sequences complementary to candidate miRNAs are as fol-
lows: miR-155 probe, 5=-CCCCTATCACGATTAGCATTAA-3=; E (XSR)
miRNA probe, 5=-CAGAGGCAACTTGAATAGTCTA-3=; and MHV68-
M1-7 probe, 5=-AATAAAGGTGGGCGCGATATC-3=. The 5.8S probe se-
quence is 5=-TTCTTCATCGACGCACGAGC-3=. The probes were end
labeled with [-32P]ATP (Amersham) and T4 polynucleotide kinase
(NewEnglandBioLabs) to generate high-specific-activity probes.Hybrid-
ization, washing, and autoradiography were carried out as previously de-
scribed (31).
Dual-luciferase assay. The transfection of DF-1 cells and Vero cells
was carried out with Lipofectamine 2000 (Invitrogen). CEFs were trans-
fected with Lipofectamine (Invitrogen), and IAH30 cells were transfected
with a Nucleofactor Transfection Kit T (Lonza). E (XSR) miRNAmimics
were synthesized by Qiagen. Approximately 3 104 cells were seeded in
each well of a 96-well plate. Except for the IAH30 cell line, which was
transfected with reporter construct alone, DF-1, CEF, and Vero cells were
cotransfectedwith 20 ng of each reporter construct in psiCHECK-2 vector
along with either 100 ng of (E) XSRmiRNA expression plasmid (DF-1) or
a final concentration of 20 nM E (XSR) miRNAmimics (DF-1, CEF, and
Vero cells) using different transfection reagents, as stated above, as per the
manufacturer’s protocols. In all cases, constitutively expressed firefly lu-
ciferase activity in the psiCHECK-2 vector served as a normalization con-
trol for transfection efficiency.
RNA polymerase II dependence assay. HEK293T cells in six-well
plates were transfected with 2.5 g of miRNA expression vector using
Lipofectamine 2000 and, where indicated, were then treated 2 h later with
a final concentration of 50 g/ml -amanitin (32). Total RNA was ex-
tracted at 24 h posttransfection, and Northern blot analysis was per-
formed.
RNA interference (RNAi) assays. Silencer Select validated siRNAs
against human Drosha (siRNA identification numbers [ID], s26491 and
s26492, referred to as D1 and D2) and Dicer (siRNA ID s23754) were
purchased from Ambion. They have been verified experimentally by the
company in cell-based assays to reduce the expression of their individual
target genes by 80% in at least three biological replicates.HEK293T cells in
six-well plates were transfected with 20 nMDrosha or Dicer siRNA using
Lipofectamine RNAi-MAX (Invitrogen) following the manufacturer’s
recommendations. At 24 h posttransfection, cells were cotransfected with
20 nM each siRNA and 2 g of miRNA expression plasmid using Lipo-
fectamine 2000. Twenty-four hours later, RNAwas extracted, and North-
ern blot analysis was performed.
Stem-loop quantitative reverse transcription-PCR (qRT-PCR) for
E (XSR) miRNA. Total RNA was extracted from cultured cells with an
miRNeasy Kit (Qiagen) according to the manufacturer’s instructions.
miRNAs were quantified using custom TaqMan stem-loop microRNA
assays (ABI) according to the manufacturer’s recommendations using 10
ng of total RNA as a template for reverse transcription with the primer
5=-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACG
ACCAGAGG-3=, followed by quantitative PCR carried out using the for-
ward primer 5=-CGGTCGACCTAGACTATTCAAGTTG-3=, reverse
primer 5=-CAGTGCAGGGTCCGAGGT-3=, and probe 5=-TGGATACGA
CCAGAGGC-3=. A TaqManmicroRNA assay for let-7a (assay ID 000377)
was purchased from ABI. Each reverse transcription reaction was per-
formed twice independently, and each reactionmixture was used for trip-
licate PCR. The level of miRNA expression is presented as fold expression
relative to the background amplification obtained with RNA isolated
from either chickenM (see Fig. 2B) or untransfected DF-1 (see Fig. 4A)
and after normalization to the ubiquitously expressed cellular miRNA
let-7a.
RESULTS
E (XSR) element encodes a novelmiRNA.DuringmiRNAprofil-
ing of an ALV-J-transformed turkey macrophage cell line IAH30
(25) by deep-sequence analysis on an IlluminaGAIIx platform,we
observed the presence of two distinct small RNA sequences that
mapped perfectly to the E (XSR) element in the 3= UTR of the
HPRS-103 genome (GenBank accession number Z46390.1). The
total reads of the two small RNA sequences account for 24.5% of
the total IAH30 “miRNAome.” Notably, only 580 reads were scat-
tered across the 7,841-bp genome outside this region. The relative
abundance (358,998 and 335 reads, respectively) (Fig. 1A and B)
and size of these small RNAs suggested they are miRNA candi-
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dates. Closer examination of the sequence revealed that it is de-
rived from the hairpin structure of the E (XSR) element (Fig. 1A).
During miRNA biogenesis, processing of the pre-miRNA yields
the more abundant miRNA and less abundant passenger strands
(33). From our data, we conclude that the abundant species that
mapped to 5= arm of the stem-loop sequence is likely to be the
miRNA strand, while the less abundant sequence that mapped to
3= arm of the stem-loop represented the passenger strand. Impor-
tantly, the 5= arm of the stem-loop sequence is the most abundant
species present in the IAH30 library (Fig. 1C). Taken together,
these results strongly suggested that we had identified a pre-
miRNA encoded within the E (XSR) element of ALV-J.
In order to confirm that these novel miRNAs identified in the
IAH30 cell linewere indeed derived from the E (XSR) sequences in
theHPRS-103 genome and did not originate from the turkey cells,
we carried out Northern blotting hybridization with the miRNA
strand probe. Northern blotting detected both mature miRNA
and pre-miRNA in IAH30 cells. No miRNAs were detected with
RNA extracted from the reticuloendotheliosis virus T (REV-T)-
transformed turkey cell line AVOL-1T and uninfected turkey
spleen cells (TSCs) (Fig. 2A). This finding was further confirmed
by TaqMan miRNA assays (Fig. 2B). IAH30 is a turkey macro-
phage cell line transformed by strain 966, an acutely transforming
virus derived fromHPRS-103. To test that the expression of the E
(XSR)-derived miRNA is not limited to the transformed macro-
phages of turkey origin, we also examined the primary chicken
macrophages infected with either HPRS-103 or 966 virus. RNA
isolated from the infected cells was tested for E (XSR) miRNA
FIG 1 The E (XSR) element in the ALV-J genome encodes a novel microRNA. (A) Genomic location of E (XSR) miRNA. The structure of the ALV-J provirus
HPRS-103 genome with the long terminal repeat (LTR), gag/pol, env (gp85 and gp37), redundant transmembrane (rTM), and the E element is shown. The
secondary structure of E (XSR) pre-miRNA predicted using the MFOLD algorithm is shown on the top. The mature miRNA strands are indicated in red. The
mature miRNAs with the number of reads for each strand recovered from deep sequencing are indicated. (B) Reads representing the major populations of E
(XSR) miRNA-5p and E (XSR) miRNA-3p aligned against the precursor sequence. Dot-bracket notation was produced by applying RNAfold. (C) Most-often-
sequenced small RNA sequences from IAH30 that map to Gallus gallusmiRNAs (gga prefix) listed in miRBase.
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expression using a TaqMan assay. Indeed, E (XSR) miRNA was
detected in cells infected with both types of viruses (Fig. 2B). Fur-
thermore, E (XSR)miRNAwas also detected in AVO4-1B3 cells, a
chicken blastoderm cell line transformed by another acutely
transforming ALV-J isolate, 1B (27), by both Northern blotting
and TaqMan miRNA assay (Fig. 2A and B). The E (XSR) miRNA
was not detected with RNA extracted frommacrophages infected
with HPRS-103 with a deletion of E (XSR) (7) or from uninfected
or REV-T-infected macrophages (Fig. 2 B). The fact that E (XSR)
miRNA was expressed in different cell types infected with a num-
ber of different ALV-J virus strains further confirmed that E (XSR)
miRNA is indeed a genuine miRNA encoded by ALV-J virus.
E (XSR)miRNAsequence is highly conserved.Wenext exam-
ined the evolutionary conservation of E (XSR)miRNAby aligning
all pre-miRNA sequences of NCBI-deposited ALV subgroup A,
subgroup J, and Rous sarcoma virus isolates with E element se-
quences along with the pre-miRNA sequence of E (XSR) miRNA
fromHPRS-103 (see Fig. S1 in the supplementalmaterial).Within
the 64 aligned pre-miRNA sequences of the E (XSR) element, the
miRNA strand (5= arm, miRNA-5p) was identical in 46 isolates,
with 16 isolates showing a single nucleotide change and the re-
maining 2 isolates showing 2-nucleotide differences. The seed re-
gion showed only a single nucleotide substitution among all the
sequences, suggesting evolutionary pressure on maintaining the
sequence of this region, potentially for modulating the expression
of its targets. The sequence of the passenger strand (3= arm,
miRNA-3p), on the other hand, showed more substitutions. The
loop region was highly conserved, and despite deletions or inser-
tions in this region, all of the pre-miRNA sequences were able to
form hairpin structures (data not shown). The fact that the
miRNA sequence is well conserved across all known ALV-J iso-
lates with an E (XSR) element suggests that this newly identified
ALV-J miRNA may have a conserved functional role.
E (XSR) miRNA is processed by the canonical miRNA bio-
genesis pathway. The vast majority of viral miRNAs are tran-
scribed by RNA polymerase II (Pol II) before being processed by
RNase III enzymes Drosha and Dicer. The exceptions are the Pol
III-derived tRNA-like precursor structures of mouse hepatitis vi-
rus 68 (MHV68) (32, 34) and the recently reported BLVmiRNAs
(22, 23, 35). In the absence of detecting any sequencemotifs of Pol
III promoter elements (22, 23) in the E (XSR) flanking sequence,
we hypothesized that this miRNA is Pol II derived. To test this, we
cloned the stem-loop structure sequence together with approxi-
mately 150 nucleotides of flanking sequence downstream of the
cytomegalovirus (CMV) promoter into pcDNA3 vector (Invitro-
gen). High-level expression of E (XSR) miRNA detected by
Northern blotting in transfectedHEK293T cells suggested that the
E (XSR)miRNA is processed by the Pol II promoter (Fig. 3A). The
hypothesis of Pol II driving expression was further explored by
testing the blockage of miRNA production by treatment with
-amanitin, a selective inhibitor of Pol II (22, 32). We transfected
HEK293T cells with the plasmid expressing E (XSR) miRNA in
pcDNA3 or pGEM-T easy vector in the presence or absence of
-amanitin. As shown in Fig. 3A, -amanitin inhibits both pre-
miRNAandmaturemiRNAof the E (XSR)miRNA, thus support-
ing our initial Pol II prediction. A cellular miRNA miR-155 tran-
scribed under the control of the Pol II promoter pEF6-Bic and a
virusmiRNA,MHV68-miR-M1-7-3p (kindly provided by C. Sul-
livan), transcribed under the control of a Pol III promoter were
used as controls. As expected, expression of both E (XSR)miRNA
and miR-155 was blocked by -amanitin treatment, whereas the
MHV68-miR-M1-7-3p miRNA was resistant (Fig. 3A). This fur-
ther confirms that the expression of E (XSR) miRNA is driven by
Pol II promoter but not Pol III promoter.
Drosha is a key enzyme in microRNA biogenesis, generating
the pre-miRNA by excising most pre-miRNA structures from Pol
II transcripts (36). To determine whether Drosha contributes to E
(XSR) miRNA processing, we used RNA interference (RNAi) to
knock down Drosha in HEK293T cells. Two Silencer Select vali-
dated siRNAs against human Drosha (Life Technologies) were
used for the knockdown of Drosha expression. We cotransfected
HEK293T cells with siRNA against Drosha and vectors expressing
either E (XSR) miRNA or control miRNA miR-155 (Fig. 3B).
Knockdown of Drosha by either siRNA resulted in a marked de-
FIG2 E (XSR)miRNA is expressed in ALV-J-transformed cells. (A)Northern blot analysis of RNA from the blastoderm cell line AVO4-1B3, turkeymacrophage
cell line IAH30, REV-T-transformed turkey spleen cell line AVOL-1T, and turkey spleen cells (TSCs) demonstrating the expression of mature and pre-miRNA
of E (XSR) miRNA. The cellular 5.8S RNA served as the loading control. (B) E (XSR) miRNA expression levels determined by qRT-PCR. Relative expression of
E (XSR) miRNA measured in RNA extracted from AVO4-1B3, IAH30, and chicken macrophages infected with either 966 (M966), HPRS-103
(MHPRS103), HPRS-103 with a deletion of the E element (MHPRS103-E), or REV-T (MRevT) as well as AVOL-1T cells and TSCs compared to
uninfected macrophage (M). Results represent the means of triplicate assays with error bars showing the standard error of the means.
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crease in the miR-155 expression which is known to be Drosha
dependent (Fig. 3B). Similar results were obtained with E (XSR)
miRNA expression following Drosha knockdown, suggesting that
E (XSR) miRNA expression is also Drosha dependent.
Dicer is the second RNA III enzyme in the miRNA biogenesis
pathway responsible for cleavage of pre-miRNA to generate ma-
ture miRNA. To confirm the contribution of Dicer to E (XSR)
miRNA expression, we cotransfected HEK293T cells with vali-
dated siRNA against Dicer (Life Technologies) and vectors ex-
pressing either E (XSR) miRNA or control miRNAmiR-155 (Fig.
3C). As expected, knockdown of Dicer resulted in an increase of
the ratio of pre-miRNA to miRNA for both E (XSR) miRNA and
Dicer-dependent miR-155 (Fig. 3C). Thus, we conclude that E
(XSR) miRNA is processed by the canonical miRNA biogenesis
pathway.
E (XSR) miRNA is a biologically functional miRNA. To de-
termine whether the E (XSR) miRNA is biologically functional,
psiCHECK-2 luciferase-based reporter plasmids, bearing four
tandem repeats of artificial target sites of perfect complementarity
to the miRNA sequence inserted into the 3= UTR (Fig. 4B), either
were cotransfected into DF-1 cells along with the E (XSR)miRNA
expression plasmid or along with the E (XSR) miRNA mimics
(Qiagen) into eitherDF-1 cells andVero cells using Lipofectamine
2000 (Invitrogen) or chicken embryo fibroblasts (CEF) using Li-
pofectamine (Invitrogen), or they were transfected into IAH30
using Nucleofactor Transfection Kit T (Lonza). The expression of
E (XSR) miRNA from transfected DF-1 and in IAH30 cells was
confirmed by quantitative TaqMan miRNA assay (Fig. 4A). As
shown in Fig. 4B, E (XSR) miRNA expressed from an expression
plasmid was able to inhibit luciferase reporter expression by 56%
in DF-1 cells relative to expression from a mutant reporter plas-
mid with four mutated nucleotides in the seed region. E (XSR)
miRNAmimics reduced the luciferase level by 68% in DF-1 cells,
88% in CEFs, and 98% in Vero cells, and the endogenous E (XSR)
miRNA in IAH30 cells could inhibit luciferase expression by 65%.
Thus, the reporter assay demonstrated that the miRNA is active
within the RNA-induced silencing complex (RISC) and that the E
(XSR) element is processed into functional mature miRNA in
DF-1 cells.
DISCUSSION
Of the 295 virus-encoded miRNAs deposited in the miRBase da-
tabase, the vast majority are encoded by DNA viruses. The small
size and lack of immunogenicity, combined with the ability for
specific repression of the expression of multiple target transcripts,
make the miRNAs ideal tools for the viruses to reshape gene ex-
pression in an infected cell to favor viral replication and patho-
genesis. Although there is a long way to go to gain significant
understanding of how thesemiRNAs function and of the portfolio
of their targets, it is clear that these small but effective regulators of
gene expression play a key role in virus biology.
Among all viruses, the members of the family Herpesviridae
account for the majority of the currently known virus-encoded
miRNAs (19, 37). In addition to the herpesviruses, a small number
of other nuclear DNA viruses, particularly polyomaviruses, have
also been shown to encode miRNAs or miRNA-like molecules
(38–45). Furthermore, no viral miRNAs have been identified us-
ing low- or high-throughput sequencing of RNA from cultured
cells infected with any of several different RNA viruses, including
hepatitis C virus (HCV), yellow fever virus (YFV),West Nile virus
(WNV), human papillomavirus (HPV), vesicular stomatitis vi-
rus (VSV), dengue virus, polio virus, human T-cell leukemia virus
type 1 (HTLV-1), and influenza A virus (21, 34, 46–48). Although
there have been several reports suggesting that HIV, an RNA virus
whose genome is reverse transcribed and incorporated into the
host DNA,may also encodemiRNAs, these reports are controver-
sial (21, 34). Thus, a widely accepted example of any naturally
RNA virus-encodedmiRNAwas lacking until the recent report of
miRNAs encoded by bovine leukemia virus (BLV), a retrovirus
with an RNA genome (22, 23). The most compelling hypothesis
for the lack of miRNA sequences in the RNA virus genome is that
excision of an miRNA from an RNA virus would result in the
cleavage and ultimately the destruction of the viral genomic RNA,
which would likely inhibit virus replication. This hypothesis is
FIG 3 E (XSR) miRNA is processed by the canonical miRNA biogenesis pathway. (A) Northern blot analysis of E (XSR) miRNA expression plasmids
pcDNA3-XSR and pGEM-T-XSR, plasmid pEF6-Bic expressingGallus gallusmiR-155 (gga-miR-155), andMHV68-miR-M1-7 expression plasmid pIDTSmart-
Kan-MHV68-miR-M1-7 transfected into HEK293T cells with or without treatment of the Pol II inhibitor -amanitin. The cellular 5.8S RNA was used as a
loading control. (B) Northern blot analysis of E (XSR) miRNA and gga-miR-155 expression vectors transfected into HEK293T cells with or without siRNA
against humanDrosha (D1 andD2). 5.8S RNAwas used as a loading control. (C) Northern blot analysis of E (XSR)miRNA and gga-miR-155 expression vectors
transfected into HEK293T cells with or without siRNA against human Dicer. 5.8S RNA was used as a loading control.
Yao et al.
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supported by the finding that BLV can overcome this obstacle by
encoding pre-miRNA structures that are only competent to be
processed into miRNAs when they are generated from sub-
genomic Pol III-derived transcripts (22, 23).
In spite of this theoretical barrier, here we provide evidence
that ALV-J uses Pol II for the production of high-level E (XSR)
miRNA. Subsequently, we have shown that the processing of the E
(XSR) miRNA is Drosha and Dicer dependent. Taken together,
this is the first example of an RNA virus that encodes an miRNA
using the canonicalmiRNAbiogenesis pathway. This suggests that
the RNA viruses could utilize different strategies to express their
own miRNAs and that they could tolerate cis cleavage within the
genome during pre-miRNA processing. Indeed, retroviruses, a
flavivirus, and influenza virus can be engineered to express bio-
logically active miRNAs or miRNA-like molecules (49–51). The
evidence of BLVmiRNAs transcribed by the Pol III promoter and
ALV E (XSR) miRNA transcribed by the Pol II promoter suggests
that future miRNA discovery efforts could be directed to other
retroviruses.
One of the conspicuous findings from the analysis of the
miRNA sequences of the IAH30 library was that E (XSR) miRNA
accounted for a quarter of the 1.469 106 sequences of the IAH30
miRNAome. An increased proportion of virus-encoded miRNAs
to host-encoded miRNAs is not uncommon in transformed cell
lines. For example, miRNAs encoded by Kaposi’s sarcoma-asso-
ciated herpesvirus and Epstein-Barr virus (EBV) accounted for
	40%of the entiremiRNA pool identified from the BC-1 cell line
coinfected with these two viruses (52). The total proportion of
virus-encoded miRNAs of Marek’s disease virus type 1 (MDV-1)
andMarek’s disease virus type 2 (MDV-2) in anMSB-1 cell library
was 61% (53). The high-level expression of viralmiRNAs has been
linked to their role in virus-induced oncogenesis since the cluster
1 miRNAs of MDV-1 andmdv1-mir-M4-5p, a member of cluster
1 miRNA and a functional ortholog of gga-mir-155 which are
highly expressed in the transformed cell lines and in tumors, have
been shown to play a key role in MDV-1-induced tumorigenesis
(54). A high level of expression of E (XSR) miRNA in the IAH30
cell line suggests that thismiRNAhas amajor role inALV-J patho-
genesis and neoplastic transformation. Although the E element
per se is not absolutely essential for tumor induction by this sub-
group of viruses, our previous work comparing the oncogenicity
of viruses derived from the parental HPRS-103 virus and from
HPRS-103 with a deletion of the E element in two genetically
distinct lines of birds showed that the E element does contribute to
oncogenicity in certain genetic lines of chicken (7). Future studies
comparing the genomes of these lines could provide insights into
the polymorphisms, including those in any potential E (XSR)
miRNA target sites that could account for such differential sus-
ceptibility phenotypes among these lines. The discoveries of the
virus-encoded miRNA targets would help us to get a clearer un-
derstanding of the role played by the viral miRNAs.
In summary, we demonstrated that an RNA virus expresses
abundant, evolutionarily conserved miRNA using the canonical
miRNA biogenesis pathway. The identification of this novel po-
tentially functional miRNA adds yet another regulatory mecha-
nism in the pathobiology of ALV and RSV.
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FIG 4 E (XSR) miRNA is a biologically functional miRNA. (A) E (XSR)
miRNA expression levels determined by qRT-PCR. Relative expression of E
(XSR) miRNAmeasured in RNA extracted frommiRNA expression plasmid-
transfected DF-1 and IAH30 cells compared to untransfected DF-1 cells. Re-
sults represent the means of triplicate assays, with error bars showing the
standard errors of the means. (B) The top panel shows a sensor construct with
four tandem repeats of artificial target sites of perfect complementarity to the
miRNA sequence inserted into the 3= UTR at the end of the Renilla luciferase
gene in psiCHECK-2 vector (sensor) and a sensor mutant (sensor-mu) con-
struct with four mutated nucleotides in the seed region. The bottom panel
shows repression of luciferase by the sensor construct relative to the mutant
construct after cotransfection with an E (XSR) miRNA expression plasmid
into DF-1 cells (a) or cotransfection with E (XSR) miRNA mimics into DF-1,
CEF, and Vero cells (b) and transfection into IAH30 (c). The relative expres-
sion of Renilla luciferase (RL) was determined with the normalized levels of
firefly luciferase. For each sample, values from four replicates representative of
at least two independent experiments were used in the analysis. SV40, simian
virus 40.
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